Results 241 to 250 of about 7,007,196 (291)
INTERIM OPIOID AGONIST TREATMENT FOR OPIOID ADDICTION. A SYSTEMATIC REVIEW.
, 2019 We plan to conduct a systematic review assessing the benefits of interim opioid agonist treatment in terms of retention in treatment, access to standard opioid agonist maintenance treatment, patient satisfaction, quality of life or wellbeing, use of psychoactive substances, criminal activities, mental and physical health status and adverse effects and ...
Ivan Solà, Laura Samsó Jofra
openaire +2 more sources
Innovations in agonist maintenance treatment of opioid-dependent patients
Current Opinion in Psychiatry, 2006 To provide an overview of published studies on agonist maintenance treatment options for opioid-dependent patients.The recent publication of controlled trials confirms earlier clinical evidence of the efficacy of diamorphine (heroin) in the treatment of opioid dependence.
Haasen, Christian, van den Brink, Wim
openaire +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Opioid agonist treatment for people who are dependent on pharmaceutical opioids
Cochrane Database of Systematic Reviews, 2022There are ongoing concerns regarding pharmaceutical opioid-related harms, including overdose and dependence, with an associated increase in treatment demand. People dependent on pharmaceutical opioids appear to differ in important ways from people who use heroin, yet most opioid agonist treatment research has been conducted in people who use heroin ...
Suzanne, Nielsen +2 more
openaire +2 more sources
Injectable opioid agonist treatment: An evolutionary concept analysis
Research in Nursing & Health, 2021AbstractCanada is currently in the midst of an overdose crisis. With new and innovative approaches desperately needed, injectable opioid agonist treatment (iOAT) should be considered as an integral treatment option to prevent even more fatalities. These programs provide injectable diacetylmorphine or hydromorphone to clients with severe opioid use ...
Marlene Haines, Patrick O'Byrne
openaire +2 more sources
Pharmacological treatment for depression during opioid agonist treatment for opioid dependence
Cochrane Database of Systematic Reviews, 2010Lifetime prevalence of depression in subjects with opioid dependence is higher than in the general population (44-54% versus 16%) and represents a risk factor for morbidity and mortality. For patients on opioid agonist treatment, current prevalence rates of depression ranges between 10 and 30%, influencing negatively the outcome of the treatment.To ...
Pier Paolo, Pani +4 more
openaire +2 more sources
Agonist treatment in opioid use: Advances and controversy
Asian Journal of Psychiatry, 2012Opioid dependence is a chronic relapsing condition which requires comprehensive care; pharmacological agents form the mainstay of its long term treatment. The two most popular approaches are the harm reduction method using agonists and the complete abstinence method using antagonists.
Biju, Viswanath +3 more
openaire +2 more sources
Nasal Opioid Agonist Treatment in Patients with Severe Opioid Dependence: A Case Series
European Addiction Research, 2021<b><i>Introduction:</i></b> Opioid agonist treatment (OAT) is the first-line treatment for opioid dependence. Currently available OAT options comprise oral (methadone and morphine) and sublingual (buprenorphine) routes of administration.
Marc, Vogel +9 more
openaire +2 more sources
Seminars in Neuroscience, 1997
Abstract After years of failures in managing heroin addiction by both supportive and punitive abstinence-based treatment modalities or incarceration, with or without initial short-term detoxification using an opioid agonist, research into the potential use of primarily mu opioid receptor directed agonist (or use of a partial agonist) in the chronic ...
openaire +1 more source
Abstract After years of failures in managing heroin addiction by both supportive and punitive abstinence-based treatment modalities or incarceration, with or without initial short-term detoxification using an opioid agonist, research into the potential use of primarily mu opioid receptor directed agonist (or use of a partial agonist) in the chronic ...
openaire +1 more source